LIGHT expression by mucosal T cells may regulate IFN-γ expression in the intestine

被引:40
作者
Cohavy, O
Zhou, J
Granger, SW
Ware, CF
Targan, SR
机构
[1] Cedars Sinai Inflammatory Bowel Dis Ctr, Los Angeles, CA 90048 USA
[2] La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA
关键词
D O I
10.4049/jimmunol.173.1.251
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The TNF superfamily of cytokines play an important role in T cell activation and inflammation. Sustained expression of lymphotoxin-like inducible protein that competes with glycoprotein D for binding herpesvirus entry mediator on T cells (LIGHT) (TNFSF14) causes a pathological intestinal inflammation when constitutively expressed by mouse T cells. In this study, we characterized LIGHT expression on activated human T cell subsets in vitro and demonstrated a direct proinflammatory effect on regulation of IFN-gamma. LIGHT was induced in memory CD45RO CD4(+) T cells and by IFN-gamma-producing CD4(+) T cells. Kinetic analysis indicated rapid induction of LIGHT by human lamina propria T cells, reaching maximal levels by 2-6 h, whereas peripheral blood or lymph node-derived T cells required 24 h. Further analysis of intestinal specimens from a 41 patient cohort by flow cytometry indicated membrane LIGHT induction to higher peak levels in lamina propria T cells from the small bowel or rectum but not colon, when compared with lymph node or peripheral blood. Independent stimulation of the LIGHT receptor, herpesvirus entry mediator, induced IFN-gamma production in lamina propria T cells, while blocking LIGHT inhibited CD2-dependent induction of IFN-gamma synthesis, indicating a role for LIGHT in the regulation of IFN-gamma and as a putative mediator of proinflammatory T-T interactions in the intestinal mucosa. Taken together, these findings suggest LIGHT-herpesvirus entry mediator mediated signaling as an important immune regulatory mechanism in mucosal inflammatory responses.
引用
收藏
页码:251 / 258
页数:8
相关论文
共 52 条
[1]   Regulation of immune responses of the intestinal mucosa [J].
AbreuMartin, MT ;
Targan, SR .
CRITICAL REVIEWS IN IMMUNOLOGY, 1996, 16 (03) :277-309
[2]  
Aranda R, 1997, J IMMUNOL, V158, P3464
[3]   Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease [J].
Bamias, G ;
Martin, C ;
Marini, M ;
Hoang, S ;
Mishina, M ;
Ross, WG ;
Sachedina, MA ;
Friel, CM ;
Mize, J ;
Bickston, SJ ;
Pizarro, TT ;
Wei, P ;
Cominelli, F .
JOURNAL OF IMMUNOLOGY, 2003, 171 (09) :4868-4874
[4]  
BLASER MJ, 1984, GASTROENTEROLOGY, V87, P888
[5]  
Brandtzaeg P, 1998, CHEM IMMUNOL, V71, P1
[6]  
Browning JL, 1997, J IMMUNOL, V159, P3288
[7]   Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology [J].
Brunner, T ;
Wasem, C ;
Torgler, R ;
Cima, I ;
Jakob, S ;
Corazza, N .
SEMINARS IN IMMUNOLOGY, 2003, 15 (03) :167-176
[8]   CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice:: Increased T helper cell type 1 response and ability to transfer disease [J].
Cong, YZ ;
Brandwein, SL ;
McCabe, RP ;
Lazenby, A ;
Birkenmeier, EH ;
Sundberg, JP ;
Elson, CO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) :855-864
[9]   NK cell and DC interactions [J].
Cooper, MA ;
Fehniger, TA ;
Fuchs, A ;
Colonna, M ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2004, 25 (01) :47-52
[10]   A METALLOPROTEASE INHIBITOR BLOCKS SHEDDING OF THE 80-KD TNF RECEPTOR AND TNF PROCESSING IN T-LYMPHOCYTES [J].
CROWE, PD ;
WALTER, BN ;
MOHLER, KM ;
OTTENEVANS, C ;
BLACK, RA ;
WARE, CF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :1205-1210